Stamford, CT -- (SBWIRE) -- 01/10/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Intercept Pharmaceuticals Inc (NASDAQ:ICPT), MannKind Corporation (NASDAQ:MNKD), Acuity Brands, Inc. (NYSE:AYI), ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) opened the session at $231.89, trading in a range of $231.31 - $305.00. The stock showed a positive performance of +281.09% in the last trading session from its previous close of $72.39 and closed at $275.87. The stock traded on a volume of 6.84 million shares and the average volume of the stock remained 231,850 shares. Intercept Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver diseases utilizing its bile acid chemistry.The Company’s product candidate, obeticholic acid, or OCA, is a bile acid analog, a chemical substance that has a structure based on a naturally occurring human bile acid. It is developing OCA initially for primary biliary cirrhosis, or PBC, as a second line treatment for patients who have an inadequate response to or who are unable to tolerate standard of care therapy and therefore need additional treatment.
For How Long ICPT will Fight for Profitability? Read This Trend Analysis report
MannKind Corporation (NASDAQ:MNKD) traded 24.88 million shares in the last business day while the average volume of the stock remained 4.96 million shares. The stock showed a positive movement of +18.39% to end at $7.08. The 52 week range of the stock remained $2.34 - $8.70. MannKind Corporation (MannKind) is a development-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. The Company’s product candidate, AFREZZA (insulin human) inhalation powder, is insulin that is in late-stage clinical investigation for the treatment of adults with type I or type II diabetes for the control of hyperglycemia.
For How Long MNKD’s Gloss will Attract Investors? Find out via this report
Acuity Brands, Inc. (NYSE:AYI) reported 1.98 million shares were exchanged during the last trade, while the average volume is about 213,001 shares. The stock escalated +12.24% and finished the day at $123.50. The beta of the stock is recorded at 1.55. Acuity Brands, Inc. (Acuity Brands), incorporated on September 20, 2007, is the parent company of Acuity Brands Lighting, Inc. (ABL), and other subsidiaries. Acuity Brands is a provider of lighting solutions for commercial, institutional, industrial, infrastructure, and residential applications throughout North America and select international markets. The Company's lighting solutions include devices, such as luminaires, lighting controls, power supplies, prismatic skylights, light-emitting diode (LED) lamps, and integrated lighting systems for indoor and outdoor applications utilizing a combination of light sources.
For How Long AYI’s Gloss will Attract Investors? Find out via this report
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) shares rose, +9.54 percent from its previous close of $42.13 to close at $46.15. Traded with volume of 2.19 million shares in the prior session and the average volume of the stock remained 1.10 million shares. Isis Pharmaceuticals, Inc. develops therapeutic drugs inhibiting cell protein synthesis. The Company's principal activity is to develop and market RNA(RiboNucleicAcid)-based novel drugs to treat important diseases such as cardiovascular diseases, diabetes and asthma.
Why Should Investors Buy ISIS After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)